Treatment of Suppurative Ear Disease

Initial Management

The American Academy of Pediatrics recommends amoxicillin-clavulanate as the first-line antibiotic treatment for acute suppurative otitis media (AOM), reducing clinical failure rates from 42-46% to 17-22% with a number needed to treat of 3-4 when using stringent diagnostic criteria 1
Amoxicillin-clavulanate should be prescribed as first-line therapy for children with confirmed AOM, targeting the primary bacterial pathogens: Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis 1
Clinical failure rates with amoxicillin-clavulanate are 17.2% for unilateral AOM and 21.7% for bilateral AOM, compared to 42.7% and 46.3% respectively with placebo 1

Observation for 48-72 hours is acceptable only in select children: those aged 6-23 months with unilateral, non-severe AOM, or children ≥24 months with unilateral or bilateral non-severe disease, provided close follow-up is ensured 1
Approximately one-third of observed children ultimately require rescue antibiotics 1
This approach can reduce antibiotic use by 65% in eligible children without increasing suppurative complications like mastoiditis 1

If symptoms persist or worsen after 48-72 hours of amoxicillin-clavulanate, escalate to intramuscular ceftriaxone 50 mg/kg daily 3, 4
A 3-day course of ceftriaxone is superior to a single dose for treatment-refractory AOM 3, 4
Do not use trimethoprim-sulfamethoxazole or erythromycin-sulfisoxazole due to substantial pneumococcal resistance 3, 4

Topical fluoroquinolone antibiotics are the first-line treatment for CSOM, not systemic antibiotics 5
Avoid ototoxic preparations (aminoglycosides) in patients with tympanic membrane perforation, as they cause permanent sensorineural hearing loss 2
Cartilage reconstruction provides superior structural outcomes compared to temporalis muscle fascia, with better graft integration rates (92.4% vs 84.3%) 5
Basic fibroblast growth factor (b-FGF) with gelatin sponge achieves 98.1% closure rates versus 10% with saline control 2

Topical antimicrobials are the primary treatment; systemic antibiotics should not be prescribed unless there is extension beyond the ear canal or specific host factors (diabetes, immunocompromised state, non-intact tympanic membrane) 6
Provide analgesics based on pain severity: acetaminophen or NSAIDs for mild-moderate pain; combination products with oxycodone or hydrocodone for moderate-severe pain 6
Keep the ear dry and avoid irrigation in patients with suspected or confirmed tympanic membrane perforation 2

Never use ototoxic ear drops (aminoglycosides) when the tympanic membrane is perforated or uncertain 2
Do not prescribe systemic antibiotics for otitis media with effusion (OME), as they provide no benefit and only increase adverse effects 7
Avoid ear irrigation in patients with tympanic membrane perforation, as this introduces infection risk 2
Do not use antihistamines or decongestants for OME management (RR 0.99, 95% CI 0.92-1.05 for benefit) 7